Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33297 publications

Transcriptional subtypes on immune microenvironment and predicting postoperative recurrence and metastasis in human pheochromocytoma and paraganglioma.

Transcriptional subtypes on immune microenvironment and predicting postoperative recurrence and metastasis in human pheochromocytoma and paraganglioma.

Journal: eLife
Published: December 16, 2025

Unveiling PAK4 as a Key Biomarker in Adrenocortical Carcinoma: Insights from Bioinformatics and Experimental Evidence.

Unveiling PAK4 as a Key Biomarker in Adrenocortical Carcinoma: Insights from Bioinformatics and Experimental Evidence.

Journal: Archivos espanoles de urologia
Published: December 03, 2025

Rare but not forgotten: Therapeutic advancements for rare childhood cancers.

Rare but not forgotten: Therapeutic advancements for rare childhood cancers.

Journal: Molecular therapy. Oncology
Published: December 01, 2025

Mild autonomic cortisol secretion: comorbidities and surgical treatment outcomes

Mild autonomic cortisol secretion: comorbidities and surgical treatment outcomes

Journal: Medicina
Published: November 28, 2025

Oligometastatic adrenocortical carcinoma: definition and treatment.

Oligometastatic adrenocortical carcinoma: definition and treatment.

Journal: Current opinion in oncology
Published: November 26, 2025

Synergistic Inhibition of PI3K and HSP90 Enhanced Antitumorigenic Efficacy in Adrenocortical Carcinoma.

Synergistic Inhibition of PI3K and HSP90 Enhanced Antitumorigenic Efficacy in Adrenocortical Carcinoma.

Journal: Research square
Published: November 24, 2025

Synergistic Inhibition of PI3K and HSP90 Enhanced Antitumorigenic Efficacy in Adrenocortical Carcinoma.

Synergistic Inhibition of PI3K and HSP90 Enhanced Antitumorigenic Efficacy in Adrenocortical Carcinoma.

Journal: Research square
Published: November 24, 2025

Corrigendum to "FGF/FGFR inhibitors downmodulate c-Myc oncoprotein and hamper the growth of adrenocortical carcinoma" [Biomed. Pharmacother. 192 (2025) 118677].

Corrigendum to "FGF/FGFR inhibitors downmodulate c-Myc oncoprotein and hamper the growth of adrenocortical carcinoma" [Biomed. Pharmacother. 192 (2025) 118677].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 23, 2025

Comparative Proteomic Profiling of Adrenocortical Neoplasia Using Mass Spectrometry.

Comparative Proteomic Profiling of Adrenocortical Neoplasia Using Mass Spectrometry.

Journal: Journal of proteome research
Published: November 21, 2025

The truth behind multiple neuroendocrine tumors: Von Hippel-Lindau syndrome and its diagnostic challenges-A case report and literature review.

The truth behind multiple neuroendocrine tumors: Von Hippel-Lindau syndrome and its diagnostic challenges-A case report and literature review.

Journal: Science progress
Published: November 21, 2025

Prevalence of Malignancy Among Incidental Indeterminate Adrenal Nodules on Contrast-Enhanced CT in Patients Without Known Cancer: A Multiinstitutional Study.

Prevalence of Malignancy Among Incidental Indeterminate Adrenal Nodules on Contrast-Enhanced CT in Patients Without Known Cancer: A Multiinstitutional Study.

Journal: AJR. American journal of roentgenology
Published: November 19, 2025

Glutamine antagonism suppresses tumor growth in adrenocortical carcinoma through inhibition of de novo nucleotide biosynthesis.

Glutamine antagonism suppresses tumor growth in adrenocortical carcinoma through inhibition of de novo nucleotide biosynthesis.

Journal: bioRxiv : the preprint server for biology
Published: November 19, 2025
Showing 1-12 of 33,297

Last Updated: 01/07/2026